Release Date: 09/02/16 10:04 Summary: Extension of T/O Offer Period Price Sensitive: Yes Download Document 196.34KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%